[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0017010A - Agentes antibacterianos 3-aminoquinazolin-2,4-diona - Google Patents

Agentes antibacterianos 3-aminoquinazolin-2,4-diona

Info

Publication number
BR0017010A
BR0017010A BR0017010-0A BR0017010A BR0017010A BR 0017010 A BR0017010 A BR 0017010A BR 0017010 A BR0017010 A BR 0017010A BR 0017010 A BR0017010 A BR 0017010A
Authority
BR
Brazil
Prior art keywords
aminoquinazolin
alkyl
antibacterial agents
dione
aryl
Prior art date
Application number
BR0017010-0A
Other languages
English (en)
Inventor
Paul Bird
Edmund Lee Ellsworth
Dai Quoc Nguyen
Joseph Peter Sanchez
Howard Daniel Hollis Showalter
Rajeshwar Singh
Michael Andrew Stier
Tuan Phong Tran
Brian Morgan Watson
Judy Yip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0017010A publication Critical patent/BR0017010A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)

Abstract

"AGENTES ANTIBACTERIANOS 3-AMINOQUINAZOLIN-2,4-DIONA". 3-Aminoquinazolin-2,4-dionas antibacterianas têm a fórmula (I) onde: R~ 1~ e R~ 3~ incluem alquila, alquenila, alquinila, cicloalquila, arila, heterocíclico e heteroarila; R~ 5~, R~ 6~ e R~ 8~ incluem H, alquila, alcóxi, halo, NO~ 2~, CN, NH~ 2~, alquila e dialquilamino; R~ 7~ inclui hidrogênio, alquila, cicloalquila, heterocíclico, heterocíclico fundido, arila e arila fundida; J e K são C ou N; e seus sais farmaceuticamente aceitáveis.
BR0017010-0A 2000-01-24 2000-12-12 Agentes antibacterianos 3-aminoquinazolin-2,4-diona BR0017010A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18
PCT/US2000/033656 WO2001053273A1 (en) 2000-01-24 2000-12-12 3-aminoquinazolin-2,4-dione antibacterial agents

Publications (1)

Publication Number Publication Date
BR0017010A true BR0017010A (pt) 2002-11-05

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0017010-0A BR0017010A (pt) 2000-01-24 2000-12-12 Agentes antibacterianos 3-aminoquinazolin-2,4-diona

Country Status (38)

Country Link
US (2) US7094780B1 (pt)
EP (1) EP1255739B1 (pt)
JP (1) JP4811978B2 (pt)
KR (1) KR20020067701A (pt)
CN (1) CN1425008A (pt)
AP (1) AP2002002603A0 (pt)
AR (1) AR030186A1 (pt)
AT (1) ATE398110T1 (pt)
AU (1) AU783078B2 (pt)
BG (1) BG107023A (pt)
BR (1) BR0017010A (pt)
CA (1) CA2393802C (pt)
CO (1) CO5320600A1 (pt)
CR (1) CR6709A (pt)
DE (1) DE60039194D1 (pt)
EA (1) EA005585B1 (pt)
EE (1) EE200200412A (pt)
ES (1) ES2304992T3 (pt)
GE (1) GEP20053429B (pt)
HK (1) HK1054237A1 (pt)
HN (1) HN2001000009A (pt)
HR (1) HRP20020696A2 (pt)
HU (1) HUP0204101A3 (pt)
IL (1) IL150393A0 (pt)
IS (1) IS6448A (pt)
MA (1) MA26866A1 (pt)
MX (1) MXPA02005989A (pt)
NO (1) NO20023516D0 (pt)
OA (1) OA12316A (pt)
PA (1) PA8510101A1 (pt)
PE (1) PE20011060A1 (pt)
PL (1) PL356837A1 (pt)
SK (1) SK10572002A3 (pt)
SV (1) SV2001000288A (pt)
TN (1) TNSN01011A1 (pt)
UY (1) UY26551A1 (pt)
WO (1) WO2001053273A1 (pt)
YU (1) YU55902A (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840599D1 (de) 1997-09-15 2009-04-09 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
JP2004532876A (ja) 2001-05-30 2004-10-28 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤
WO2002102793A2 (en) * 2001-06-19 2002-12-27 Warner-Lambert Company Llc Quinazolinediones as antibacterial agents
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
JP2007505096A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー キノロン抗菌剤
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
JP2007511597A (ja) * 2003-11-18 2007-05-10 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌アミノキナゾリヂンヂオン誘導体
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
ATE447572T1 (de) * 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
PT2001862E (pt) 2006-03-28 2011-07-20 Warner Chilcott Co Llc Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
CA2647454A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
AU2009209811B2 (en) * 2008-01-30 2011-07-21 Shin Poong Pharmaceutical Co., Ltd. Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
AR085806A1 (es) 2011-03-15 2013-10-30 Trius Therapeutics Inc Inhibidores triciclicos de girasa
RU2618673C2 (ru) * 2011-12-21 2017-05-10 Цзянсу Хэнжуй Медсин Ко., Лтд. Производные пирролопиримидина, полезные в качестве ингибиторов jak-киназы
SI3495367T1 (sl) 2012-06-13 2021-01-29 Incyte Holdings Corporation Substituirane triciklične spojine kot zaviralci FGFR
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
CN105189505B (zh) 2012-09-12 2019-03-22 默克夏普&多梅有限公司 用作抗菌剂的三环促旋酶抑制剂
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
JP6449244B2 (ja) 2013-04-19 2019-01-09 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Fgfr抑制剤としての二環式複素環
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
AU2016219822B2 (en) 2015-02-20 2020-07-09 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
EA202092649A1 (ru) 2018-05-04 2021-06-21 Инсайт Корпорейшн Соли ингибитора fgfr
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
AU2020366006A1 (en) 2019-10-14 2022-04-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CN115151539A (zh) 2019-12-04 2022-10-04 因赛特公司 Fgfr抑制剂的衍生物
JP2023505258A (ja) 2019-12-04 2023-02-08 インサイト・コーポレイション Fgfr阻害剤としての三環式複素環
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
CA3215903A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
AR126102A1 (es) 2021-06-09 2023-09-13 Incyte Corp Heterociclos tricíclicos como inhibidores de fgfr

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (pt) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
ATE8626T1 (de) * 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) * 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
WO1994014809A1 (de) 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellierte uracilderivate
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
SI1028950T1 (en) * 1997-10-28 2003-08-31 Warner-Lambert Company Llc 7-substituted quinazolin-2,4-diones useful as antibacterial agents
PL344248A1 (en) * 1998-05-26 2001-10-22 Warner Lambert Co Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
TR200101644T2 (tr) * 1998-12-11 2001-11-21 F.Hoffmann-La Roche Ag TNF-ALFA önleyicileri olarak siklik hidrazin türevleri.

Also Published As

Publication number Publication date
EP1255739A1 (en) 2002-11-13
US20060287308A1 (en) 2006-12-21
HN2001000009A (es) 2001-06-13
HK1054237A1 (zh) 2003-11-21
CN1425008A (zh) 2003-06-18
OA12316A (en) 2006-05-15
HRP20020696A2 (en) 2003-12-31
AU2089901A (en) 2001-07-31
EE200200412A (et) 2003-10-15
CO5320600A1 (es) 2003-09-30
GEP20053429B (en) 2005-01-25
NO20023516L (no) 2002-07-23
UY26551A1 (es) 2001-04-30
ATE398110T1 (de) 2008-07-15
HUP0204101A3 (en) 2004-05-28
US20060183762A1 (en) 2006-08-17
DE60039194D1 (de) 2008-07-24
MXPA02005989A (es) 2002-10-23
AR030186A1 (es) 2003-08-13
BG107023A (en) 2003-04-30
AP2002002603A0 (en) 2002-09-30
CR6709A (es) 2003-11-25
HUP0204101A2 (hu) 2003-04-28
ES2304992T3 (es) 2008-11-01
AU783078B2 (en) 2005-09-22
PA8510101A1 (es) 2003-06-30
EA005585B1 (ru) 2005-04-28
US7582627B2 (en) 2009-09-01
SV2001000288A (es) 2001-11-30
MA26866A1 (fr) 2004-12-20
JP2003520277A (ja) 2003-07-02
IS6448A (is) 2002-06-27
YU55902A (sh) 2006-01-16
EP1255739B1 (en) 2008-06-11
US7094780B1 (en) 2006-08-22
JP4811978B2 (ja) 2011-11-09
NO20023516D0 (no) 2002-07-23
CA2393802C (en) 2011-04-19
IL150393A0 (en) 2002-12-01
SK10572002A3 (sk) 2003-10-07
PE20011060A1 (es) 2001-10-12
WO2001053273A1 (en) 2001-07-26
KR20020067701A (ko) 2002-08-23
TNSN01011A1 (en) 2005-11-10
CA2393802A1 (en) 2001-07-26
PL356837A1 (en) 2004-07-12
EA200200661A1 (ru) 2003-02-27

Similar Documents

Publication Publication Date Title
BR0017010A (pt) Agentes antibacterianos 3-aminoquinazolin-2,4-diona
BR0205890A (pt) Pirazolopirimidinas como agentes terapêuticos
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
TW342310B (en) Non-systemic external dermal control of parasites
DK0729461T3 (da) Fungicide cykliske amider
ES2187473T3 (es) Triarylimidazoles.
NO20012567L (no) Azepinoindolderivater, fremstilling og anvendelse derav
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
BR0111561A (pt) Composto pirrolo[2,3-d] pirimidina como agentes imunossupressores
NO995846D0 (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
NO971471L (no) Nye karboksamider med fungicid aktivitet
DE602006004865D1 (de) Antimykotische mittel
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
BR0214151A (pt) Compostos orgânicos
EP1243268A4 (en) MEDICINAL COMPOSITION
ATE277042T1 (de) Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur
MXPA04006041A (es) Antivirales de piridoquinoxalina.
NO984414D0 (no) Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
YU44202A (sh) Kvaternerne soli n-substituisanih cikiličnih ili ne- cikličnih amina kao farmaceutski preparati
TW200505926A (en) 1,4-diazabicyclo [3.2.2] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07D 239/96, C07D 403/04, C07D 471/04, C07D 471/06, C07D 498/06, C07D 403/14, C07D 519/00, C07D 487/04, C07D 487/10, C07D 413/04, C07D 417/04, C07D 409/04, A61K 31/505, A61P 31/04

Ipc: C07D 239/96 (2009.01), C07D 403/04 (2009.01), C07D

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII), 11, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.